Skip to content
Catalyst

resveratrolFinding

Resveratrol decreases glycated haemoglobin (HbA1c)

lowersModerate evidenceFindingreplicated ×3

01 · The sentence it was drawn from

“There was a significant decrease following RSV administration in WC with an SMD of –0.36 (95% CI: –0.59 to –0.14; P = 0.002; I2 = 88%), hemoglobin A1c (HbA1c): –0.48 (–0.69 to –0.2; P ≤ 0.001; I2 = 94%), TC: –0.15 (–0.3 to –0.01; P = 0.003; I2 = 94%), low-density lipoprotein cholesterol (LDL-C): –0.42 (–0.57 to –0.27; P ≤ 0.001; I2 = 92%), and HDL-C:0.16 (–0.31 to –0.02; P = 0.03; I2 = 81%).”
Quoted verbatim from Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review.
This finding among the 73 findings on its endpoint

resveratrol

Glycated haemoglobin (HbA1c)

lowers

Effect as reported

−0.48standardised mean difference

CI −0.69 to −0.2

Who
adults, mostly obese and diabetic patients, RSV vs placebo, pooled from 25 RCTs (1,171 participants)
Dose studied
not reported

Moderate evidencePMID 35431994 · 2022

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3RM64Q2BJXRT1X3FCXVE7Q7